Biomarkers in Patients Undergoing Mechanical Ventilation
VAP
Observational Study in Patients Admitted in the Intensive Care Unit.Tracheal Bacterial Load Surveillance in Patients Undergoing Mechanical Ventilation - Assessment of Biomarkers in the Distinction Between Colonization and Infection
2 other identifiers
observational
211
1 country
1
Brief Summary
To evaluate in a cohort of patients on mechanical ventilation, for non-infectious reasons and for documented sepsis of pulmonary as well as non-pulmonary origin, the bacterial load, procalcitonine (PCT), C-Reactive Protein (CRP), temperature, White cell count (WCC), American College of Chest Physicians/Society of Critical Care Medicine (ACCP/SCCM) consensus conference criteria, Sequential Organ Failure Assessment score (SOFA) and simplified Clinical Pulmonary Infection Score (CPIS) through the mechanical ventilation period
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 3, 2012
CompletedFirst Posted
Study publicly available on registry
March 5, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2015
CompletedApril 4, 2017
April 1, 2017
2 years
August 3, 2012
April 3, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Procalcitonine (PCT) levels evolution
Procalcitonin (PCT) levels assessed daily up to 21 days
Up to 21 days
Secondary Outcomes (2)
C-Reactive Protein (CRP)
Up to 21 days
Biomarkers at day of Ventilator-Adquired Pneumonia (VAP)
Up to 21 days
Study Arms (3)
Control Grup
* Daily clinical data collection * Quantitative tracheal aspirates (QTA) every 3 days * Deep freeze serum samples for posterior analysis every day (two aliquots). * In patients with documented pneumonia daily collection of the following variables will continue: CRP, PCT, ABG, mechanical ventilation parameters, ACCP/SCCM consensus conference criteria, simplified CPIS, SOFA.
Patients with pulmonary infection
* Daily clinical data collection * Quantitative tracheal aspirates (QTA) every 3 days * Deep freeze serum samples for posterior analysis every day (two aliquots). * In patients with documented pneumonia daily collection of the following variables will continue: CRP, PCT, ABG, mechanical ventilation parameters, ACCP/SCCM consensus conference criteria, simplified CPIS, SOFA.
Patients with extrapulmonary infection
* Daily clinical data collection * Quantitative tracheal aspirates (QTA) every 3 days * Deep freeze serum samples for posterior analysis every day (two aliquots). * In patients with documented pneumonia daily collection of the following variables will continue: CRP, PCT, ABG, mechanical ventilation parameters, ACCP/SCCM consensus conference criteria, simplified CPIS, SOFA.
Eligibility Criteria
Patients admitted in the ICU
You may qualify if:
- Patients admitted in the ICU, with an expected length of mechanical ventilation \> 3 days.
- Not receiving antibiotics for \>24 hrs before ICU admission- An expected length of mechanical ventilation \> 3 days
You may not qualify if:
- Patients \<18 yrs old
- Pregnancy and lactation
- Fulminant hepatic failure
- Pancreatitis
- Patients with the diagnosis of disseminated cancer, expected to die or undergo withdrawal of treatment within 72 hours after enrolment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Corporacion Parc Taulilead
- Hospital Universitari Vall d'Hebron Research Institutecollaborator
- Hospital Clinic of Barcelonacollaborator
- Centro Hospitalar Lisboa Ocidentalcollaborator
- Hospital Universitario La Fecollaborator
Study Sites (1)
Hospital Parc TaulĂ
Sabadell, Barcelona, 08208, Spain
Related Publications (4)
Povoa P, Martin-Loeches I, Ramirez P, Bos LD, Esperatti M, Silvestre J, Gili G, Goma G, Berlanga E, Espasa M, Goncalves E, Torres A, Artigas A. Biomarker kinetics in the prediction of VAP diagnosis: results from the BioVAP study. Ann Intensive Care. 2016 Dec;6(1):32. doi: 10.1186/s13613-016-0134-8. Epub 2016 Apr 14.
PMID: 27076187RESULTMartin-Loeches I, Bos LD, Povoa P, Ramirez P, Schultz MJ, Torres A, Artigas A. Tumor necrosis factor receptor 1 (TNFRI) for ventilator-associated pneumonia diagnosis by cytokine multiplex analysis. Intensive Care Med Exp. 2015 Dec;3(1):26. doi: 10.1186/s40635-015-0062-1. Epub 2015 Sep 16.
PMID: 26377207RESULTCeccato A, Camprubi-Rimblas M, Bos LDJ, Povoa P, Martin-Loeches I, Forne C, Areny-Balaguero A, Campana-Duel E, Morales-Quinteros L, Quero S, Ramirez P, Esperatti M, Torres A, Blanch L, Artigas A. Evaluation of the Kinetics of Pancreatic Stone Protein as a Predictor of Ventilator-Associated Pneumonia. Biomedicines. 2023 Sep 29;11(10):2676. doi: 10.3390/biomedicines11102676.
PMID: 37893050DERIVEDPovoa P, Martin-Loeches I, Ramirez P, Bos LD, Esperatti M, Silvestre J, Gili G, Goma G, Berlanga E, Espasa M, Goncalves E, Torres A, Artigas A. Biomarkers kinetics in the assessment of ventilator-associated pneumonia response to antibiotics - results from the BioVAP study. J Crit Care. 2017 Oct;41:91-97. doi: 10.1016/j.jcrc.2017.05.007. Epub 2017 May 8.
PMID: 28502892DERIVED
Biospecimen
Bronchoalveolar lavage,biochemical lab,exhaled air.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
torres antonio, doctor
hospital vall hebron barcelona
- PRINCIPAL INVESTIGATOR
palomar mercedes, doctor
Hospital Clinic i provincial de Barcelona
- PRINCIPAL INVESTIGATOR
povoa pedro, doctor
Centro hospitalario de lisboa occidental
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
August 3, 2012
First Posted
March 5, 2014
Study Start
September 1, 2008
Primary Completion
September 1, 2010
Study Completion
September 1, 2015
Last Updated
April 4, 2017
Record last verified: 2017-04